Trump directs HHS, FDA to require full safety warnings in drug ads
President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies to include full safety warnings on their consumer advertisements. HHS and the FDA announced they will remove a loophole from a 1997 provision that allowed drug advertisers to display safety information in a different format or location. Additionally, HHS said the FDA would begin aggressive enforcement of direct-to-consumer violations.
Related News Articles
Headline
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…
Headline
A JAMA Internal Medicine study published April 7 examined the effects of changing the default prescription lengths for statins, which are cholesterol-lowering…
Headline
The Administration for Strategic Preparedness and Response July 16 announced it will work with the Department of Commerce on an assessment of the active…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…
Headline
Deanna Martin, AHA’s vice president for professional membership groups, highlights the valuable insights to be gained by marketing, communications and business…
Headline
The Food and Drug Administration yesterday revised its recent guidance for outsourcing facilities compounding certain ibuprofen oral suspension products…